Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children

Journal of Diarrhoeal Diseases Research

Volumn 14, Issue 4, 1996, Pages 243-247

  Kabir, Iqbal ^a   Khan, Wasif Ali ^a   Haider, Rukhsana ^a   Mitra, Amal K ^a   Alam, Ahmed Nurul ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Cholera; Drug resistance; Erythromycin; Microbial; Sulphamethoxazole; Trimethoprim; Vibrio cholerae

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; FURAZOLIDONE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHOLERA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FECES CULTURE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CHOLERA; ERYTHROMYCIN; HUMANS; INFANT; MALE; PILOT PROJECTS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030437701     PISSN: 02538768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Khan MU, Eeckels R, Alam AN, Rahman N. Cholera, rotavirus and ETEC diarrhoea: some clinico-epidemiological features. Trans R Soc Trop Med Hyg 1988;82:485-8.
2. Lindenbaum J, Greenough WB, III, Islam MR. Antibiotic therapy of Cholera. Bull WHO 1967;36:871-83.
3. De S, Choudhuri A, Dutta P, Dutta D, De SP, Pal SC. Doxycycline in the treatment of cholera. Bull WHO 1976;54:177-9.
4. Wallace CK, Anderson PN, Brown TC, Khanra SR, Lewis GW, Pierce NF, et al. Optimal antibiotic therapy in cholera. Bull WHO 1968;39:239-45.
5. Alam AN, Alam NH, Ahmed T, Sack DA. Randomised double blind trial of single dose doxycycline for treating cholera in adults. Br Med J 1990;300:1619-21.
6. Rabbani GH, Islam MR, Butler T, Shahrier M, Alam K. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. Atimicrob Agents Chemother 1989;33:1447-50.
7. Candau MG. The seventh cholera pandemic. WHO Chron 1971;25:155-60.
8. Glass RI, Huq I, Alim ARMA, Yunus M. Emergence of multiply antibiotic-resistance Vibrio choleras El Tor in Bangladesh. J Infect Dis 1980;142:939-42.
9. Towner KJ, Pearson NJ, Mhalu FS, O'Grady F. Resistance to antimicrobial agents of Vibrio choleras El Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull WHO 1980;58:747-51.
10. Maimone F, Coppo A, Pazzani C, Ismail SO, Guerra R, Procacci P, et al. Clonal spread of multiply resistant strains of Vibrio cholerae O1 in Somalia. J Infect Dis 1986;153:802-3.
11. Finch MJ, Moriss G, Jr., Kaviti J, Kagwanja W, Levine MM. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. J Trop Med Hyg 1988;39:484-90.
12. Molla AM, Sarker SA, Hossain M, Molla A, Greenough WB, III. Rice-powder electrolyte solution as oral therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet 1982;1:1317-9.
13. Cash RA, Northrup RS, Rahman ASMM. Trimethoprim and sulphamethoxazole in clinical cholera: comparison with tetracycline. J Infect Dis 1973;128(suppl):749-53.
14. Gharagozloo RA, Naficy K, Mouin M, Nassirzadeh MH, Yalda R. Comparative trial of tetracycline, chloramphenicol, and trimethoprim sulphamethoxazole in eradication of Vibrio cholerae El Tor. Br Med J 1970;4:281-2.
15. Uylangco C, Santiago L, Pescante M, Menday P, Christensen O. Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp. J Antimicrob Chemother 1984;13:171-5.
16. Burans JP, Podgore J, Mansour MM, Farah AH, Abbas S, AbuElyazeed R, et al. Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistant V. cholerae O1. Trans R Soc Trop Med Hyg 1989;83:836-8.
17. Siddique AK, Baqui AH, Eusof A, Haider K, Hossain MA, Bashir I, et al. Survival of classic cholera in Bangladesh. Lancet 1991;337:1125-7.
18. Siddique AK, Zaman K, Majumder Y, Islam Q, Bashir I. Mutsuddy P, et al. Simultaneous outbreaks of contrasting drug resistant classic and El Tor Vibrio choleras O1 in Bangladesh (letter). Lancet 1989;2:396.
19. Thretall EJ, Rowe B, Huq I. Plasmid-encoded multiple antibiotic resistance in Vibrio choleras El Tor from Bangladesh. Lancet 1980;1:1247-8.
20. Fule RP, Powar RM, Menon S, Basutkar SH, Saoji AM. Cholera epidemic in Solapur during July-August, 1988. Indian J Med Res 1990;91:24-6.
21. Bhattacharya SK, Bhattacharya MK, Dutta P, Dutta D, De SP, Sikder SN, et al. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob Agents Chemother 1990;34:939-40.
22. Irgham B, Brentnal DW, Dale EA, McFadzean JA. Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol Lett 1977;1:21-6.